Regulatory B cells in autoimmune diseases: how do they work?

Area of Science:

• Immunology
• Autoimmunity Research
• Cellular Biology

Background:

• B lymphocytes are implicated in autoimmune disease pathogenesis, with B-cell depletion therapies showing clinical benefits.
• However, B-cell depletion can worsen autoimmune conditions in some models, suggesting a complex, potentially dual role for B cells.
• This indicates the existence of distinct B cell populations, including pathogenic and regulatory B cells (Bregs).

Purpose of the Study:

• To explore the multifaceted role of B cells in autoimmune disorders.
• To identify and characterize different subsets of regulatory B cells (Bregs).
• To understand the mechanisms by which Bregs modulate autoimmune responses.

Main Methods:

• Review of existing literature on B cell subsets and their functions in autoimmunity.
• Analysis of studies involving B cell depletion in murine models of autoimmune diseases.
• Examination of the molecular signals and cellular interactions involved in Breg activation and function.

Main Results:

• B cells exhibit ambivalent roles in autoimmunity; some are pathogenic, while others possess regulatory functions.
• Multiple Breg subsets exist, including autoreactive B cells, marginal zone B cells, transitional type 2-like B cells, and CD5(+) B cells.
• Breg activity is induced by B-cell receptor, CD40, or TLR9 signaling and mediated via IL-10 or cell-to-cell contact (CD40, B7).

Conclusions:

• Breg cells are integral to controlling autoimmunity within complex cellular networks that vary by pathology.
• Targeted cells modulated by Bregs include autoreactive T cells, dendritic cells, macrophages, and regulatory T lymphocytes.
• Optimizing Breg stimulation and control is essential for their therapeutic application in autoimmune diseases.